am 580 has been researched along with agn 193836 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beard, RL; Chandraratna, RA; Duong, TT; Klein, ES; Standevan, AM; Teng, M | 1 |
| Chandraratna, RA; Duong, TT; Klein, ES; Pino, ME; Teng, M | 1 |
| Adams, DR; Barlow, S; Borthwick, AD; Brown, JT; Clarke, E; Corcoran, JPT; Goncalves, MB; Jarvis, CI; Kalindjian, SB; Miller, I; Ravier, E; Shiers, JJ; Smith, V; Taddei, DMA | 1 |
3 other study(ies) available for am 580 and agn 193836
| Article | Year |
|---|---|
Synthesis and biological activity of retinoic acid receptor-alpha specific amides.
Topics: Amides; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Hydrogen Bonding; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoids; Structure-Activity Relationship | 2002 |
Identification of a retinoic acid receptor alpha subtype specific agonist.
Topics: Aminobenzoates; Animals; Benzoates; Cell Line; Dose-Response Relationship, Drug; Genes, Reporter; Molecular Structure; Protein Binding; Receptors, Retinoic Acid; Recombinant Fusion Proteins; Retinoic Acid Receptor alpha; Retinoid X Receptors; Retinoids; Tetrahydronaphthalenes; Transcription Factors; Transcriptional Activation; Transfection | 1996 |
Design and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist.
Topics: Administration, Oral; Aminobenzoates; Animals; Benzoates; Cell Survival; Chlorocebus aethiops; COS Cells; Drug Design; Half-Life; Hep G2 Cells; Humans; Mice; Microsomes, Liver; Rats; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Structure-Activity Relationship; Tetrahydronaphthalenes | 2018 |